Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Haematologica
|
March 4, 2014
The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
Elske Quak, Narinée Hovhannisyan, Charline Lasnon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 28, 2017
Assessment of alteration in liver <sup>18</sup>F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
Thibault Salomon, Catherine Nganoa, Anne-Claire Gac, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 9, 2013
Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients
Charline Lasnon, Cédric Desmonts, Elske Quak, et al.
Annals of Nuclear Medicine
|
March 26, 2021
Revisiting detection of in-transit metastases in melanoma patients using digital <sup>18</sup>F-FDG PET/CT with small-voxel reconstruction
Pierre-André Zimmermann, Benjamin Houdu, Laure Césaire, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 22, 2016
<sup>18</sup>F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer
Charline Lasnon, Mohamed Majdoub, Brice Lavigne, et al.
Leukemia & Lymphoma
|
July 5, 2021
End-of-treatment <sup>18</sup>F-FDG PET/CT in diffuse large B cell lymphoma patients: ΔSUV outperforms Deauville score
François Allioux, Damaj Gandhi, Jean-Pierre Vilque, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2018
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
Benjamin Houdu, Charline Lasnon, Idlir Licaj, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 12, 2018
Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
Benjamin Houdu, Charline Lasnon, Idlir Licaj, et al.
EJNMMI Research
|
February 9, 2021
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
Nicolas Aide, Laurent Poulain, Nicolas Elie, et al.
Molecular Imaging and Biology
|
December 4, 2014
NEMA NU 4-Optimized Reconstructions for Therapy Assessment in Cancer Research with the Inveon Small Animal PET/CT System
Charline Lasnon, Audrey Emmanuelle Dugue, Mélanie Briand, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Haematologica
|
March 4, 2014
The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
Elske Quak, Narinée Hovhannisyan, Charline Lasnon, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 28, 2017
Assessment of alteration in liver <sup>18</sup>F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
Thibault Salomon, Catherine Nganoa, Anne-Claire Gac, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 9, 2013
Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients
Charline Lasnon, Cédric Desmonts, Elske Quak, et al.
Annals of Nuclear Medicine
|
March 26, 2021
Revisiting detection of in-transit metastases in melanoma patients using digital <sup>18</sup>F-FDG PET/CT with small-voxel reconstruction
Pierre-André Zimmermann, Benjamin Houdu, Laure Césaire, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 22, 2016
<sup>18</sup>F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer
Charline Lasnon, Mohamed Majdoub, Brice Lavigne, et al.
Leukemia & Lymphoma
|
July 5, 2021
End-of-treatment <sup>18</sup>F-FDG PET/CT in diffuse large B cell lymphoma patients: ΔSUV outperforms Deauville score
François Allioux, Damaj Gandhi, Jean-Pierre Vilque, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2018
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
Benjamin Houdu, Charline Lasnon, Idlir Licaj, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 12, 2018
Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
Benjamin Houdu, Charline Lasnon, Idlir Licaj, et al.
EJNMMI Research
|
February 9, 2021
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
Nicolas Aide, Laurent Poulain, Nicolas Elie, et al.
Molecular Imaging and Biology
|
December 4, 2014
NEMA NU 4-Optimized Reconstructions for Therapy Assessment in Cancer Research with the Inveon Small Animal PET/CT System
Charline Lasnon, Audrey Emmanuelle Dugue, Mélanie Briand, et al.
Page
of 6